{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:28:21Z","timestamp":1768001301421,"version":"3.49.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"am","delay-in-days":262,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.lpm.2023.104185","type":"journal-article","created":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T17:26:16Z","timestamp":1697995576000},"page":"104185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Heart failure with preserved ejection fraction: New challenges and new hopes"],"prefix":"10.1016","volume":"53","author":[{"given":"Damien","family":"Logeart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2023.104185_bib0001","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0002-9149(84)80207-6","article-title":"Congestive heart failure with normal systolic function","volume":"54","author":"Dougherty","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM200101043440103","article-title":"The pathogenesis of acute pulmonary edema associated with hypertension","volume":"344","author":"Gandhi","year":"2001","journal-title":"N Engl J Med"},{"issue":"9386","key":"10.1016\/j.lpm.2023.104185_bib0003","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.lpm.2023.104185_bib0004","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.lpm.2023.104185_bib0005","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lpm.2023.104185_bib0006","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCHEARTFAILURE.111.966366","article-title":"Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction","volume":"5","author":"Dunlay","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.lpm.2023.104185_bib0007","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jchf.2018.11.019","article-title":"Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure","volume":"7","author":"Savarese","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0008","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Redfield MM Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nature Reviews Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0009","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","article-title":"Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort","volume":"33","author":"Vasan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0010","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0002-9149(00)01165-6","article-title":"Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study","volume":"86","author":"Devereux","year":"2000","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.lpm.2023.104185_bib0011","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.lpm.2023.104185_bib0012","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American heart association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2023.104185_bib0013","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2023.104185_bib0014","first-page":"678","article-title":"Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"JACC: Heart Failure"},{"issue":"9","key":"10.1016\/j.lpm.2023.104185_bib0015","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.amjcard.2011.06.044","volume":"108","author":"Maga\u00f1a-Serrano","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0016","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/jama.296.18.2209","article-title":"Systolic and diastolic heart failure in the community","volume":"296","author":"Bursi","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2023.104185_bib0017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2023.104185_bib0018","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-137-8-200210150-00006","article-title":"Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study","volume":"137","author":"Gottdiener","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2023.104185_bib0019","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.lpm.2023.104185_bib0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2023.104185_bib0021","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.lpm.2023.104185_bib0022","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","article-title":"Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review","volume":"73","author":"McHugh","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.lpm.2023.104185_bib0023","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets","volume":"118","author":"Borlaug","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"17","key":"10.1016\/j.lpm.2023.104185_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021660","article-title":"Coronary artery disease and heart failure with preserved ejection fraction: the ARIC study","volume":"11","author":"John","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.lpm.2023.104185_bib0025","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamacardio.2021.1825","article-title":"Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"6","author":"Rush","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0026","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2010.03.077","article-title":"Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction","volume":"56","author":"Borlaug","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0027","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","article-title":"Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure","volume":"288","author":"Kitzman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2023.104185_bib0028","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrcardio.2012.123","article-title":"The many faces of heart failure with preserved ejection fraction","volume":"9","author":"Shah","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0029","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.106.659763","article-title":"Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County","volume":"115","author":"Lam","year":"2007","journal-title":"Minnesota. Circulation."},{"key":"10.1016\/j.lpm.2023.104185_bib0030","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/hrt.2010.212787","article-title":"Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction","volume":"97","author":"Borlaug","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.lpm.2023.104185_bib0031","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/eurheartj\/ehy268","article-title":"Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction","volume":"39","author":"Obokata","year":"2018","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.lpm.2023.104185_bib0032","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2023.104185_bib0033","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2018.04.039","article-title":"Myocardial injury and cardiac reserve in patients with heart failure and preserved ejection fraction","volume":"72","author":"Obokata","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0034","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jacc.2013.09.052","article-title":"Impaired systolic function by strain imaging in heart failure with preserved ejection fraction","volume":"63","author":"Kraigher-Krainer","year":"2014","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacc.2009.03.037","article-title":"The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion","volume":"54","author":"Tan","year":"2009","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0036","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jacc.2009.05.012","article-title":"Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency","volume":"54","author":"Phan","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.lpm.2023.104185_bib0037","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCHEARTFAILURE.109.877720","article-title":"Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction","volume":"3","author":"Phan","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0038","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCHEARTFAILURE.114.001667","article-title":"Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction","volume":"8","author":"Melenovsky","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.lpm.2023.104185_bib0039","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003754","article-title":"Prognostic utility and clinical significance of cardiac mechanics in heart failure with preserved ejection fraction: importance of left atrial strain","volume":"9","author":"Freed","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.lpm.2023.104185_bib0040","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lpm.2023.104185_bib0041","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.117.030093","article-title":"High prevalence of occult heart failure with preserved ejection fraction among patients with atrial fibrillation and dyspnea","volume":"137","author":"Reddy","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lpm.2023.104185_bib0042","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ejhf.2122","article-title":"A prospective STudy using invAsive haemodynamic measurements foLLowing catheter ablation for AF and early HFpEF: STALL AF-HFpEF","volume":"23","author":"Sugumar","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0043","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.1464","article-title":"Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction","volume":"21","author":"Reddy","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0044","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ejhf.645","article-title":"Global left atrial failure in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0045","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jacc.2017.01.051","article-title":"Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives","volume":"69","author":"Guazzi","year":"2017","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0046","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamacardio.2018.0128","article-title":"Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction","volume":"3","author":"Vanderpool","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0047","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1093\/eurheartj\/ehw241","article-title":"Abnormal right ventricular- pulmonary artery coupling with exercise in heart failure with preserved ejection fraction","volume":"37","author":"Borlaug","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2023.104185_bib0048","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.113.008461","article-title":"Right ventricular function in heart failure with preserved ejection fraction: a community-based study","volume":"130","author":"Mohammed","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2023.104185_bib0049","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"van Heerebeek","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2023.104185_bib0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jacc.2017.05.029","article-title":"Arterial stiffening with exercise in patients with heart failure and preserved ejection fraction","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0051","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2011.10.873","article-title":"Increased proximal arterial stiffness and cardiac response with moderate exercise in patients with heart failure and preserved ejection fraction","volume":"59","author":"Tarti\u00e8re-Kesri","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0052","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ejhf.2254","article-title":"Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction","volume":"23","author":"Sorimachi","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.lpm.2023.104185_bib0053","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.lpm.2023.104185_bib0054","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.lpm.2023.104185_bib0055","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","article-title":"From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited","volume":"128","author":"Paulus","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.lpm.2023.104185_bib0056","article-title":"Circ heart fail","volume":"13","author":"Sabbah","year":"2020","journal-title":"Obese-Inflammatory Phenotypes Heart Failure With Preserved Ejection Fraction"},{"issue":"5","key":"10.1016\/j.lpm.2023.104185_bib0057","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ahj.2012.08.014","article-title":"Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction","volume":"164","author":"Bishu","year":"2012","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.lpm.2023.104185_bib0058","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/heartjnl-2015-307787","article-title":"From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress","volume":"102","author":"Franssen","year":"2016","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.lpm.2023.104185_bib0059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201836","article-title":"High-sensitivity C-reactive protein in heart failure with preserved ejection fraction","volume":"13","author":"DuBrock","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lpm.2023.104185_bib0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"issue":"48","key":"10.1016\/j.lpm.2023.104185_bib0061","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1093\/eurheartj\/ehy596","article-title":"Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology","volume":"39","author":"Maack","year":"2018","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.lpm.2023.104185_bib0062","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1113\/JP276747","article-title":"Cardiomyopathy in obesity, insulin resistance and diabetes","volume":"598","author":"Nakamura","year":"2020","journal-title":"J Physiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0063","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2023.104185_bib0064","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0065","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jchf.2018.07.009","article-title":"Adiposity and incident heart failure and its subtypes: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"6","author":"Rao","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0066","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","article-title":"Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction","volume":"42","author":"Sorimachi","year":"2021","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.lpm.2023.104185_bib0067","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2012.05.014","article-title":"Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction","volume":"110","author":"Anjan","year":"2012","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.lpm.2023.104185_bib0068","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ehf2.12235","article-title":"Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction","volume":"5","author":"Buckley","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0069","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.lpm.2023.104185_bib0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.lpm.2023.104185_bib0071","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCHEARTFAILURE.113.000383","article-title":"Longitudinal changes in left ventricular stiffness: a community-based study","volume":"6","author":"Borlaug","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0072","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/ehjci\/jeab154","article-title":"Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging","volume":"23","author":"Smiseth","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.lpm.2023.104185_bib0073","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ejhf.2377","article-title":"Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity","volume":"24","author":"Obokata","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0074","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcmg.2019.01.037","article-title":"Diastolic stress test: invasive and noninvasive testing","volume":"13","author":"Ha","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.lpm.2023.104185_bib0075","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"Evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"issue":"40","key":"10.1016\/j.lpm.2023.104185_bib0076","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.lpm.2023.104185_bib0077","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/ejhf.2601","volume":"24","author":"Guazzi","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0078","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2023.104185_bib0079","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ejhf.1621","article-title":"Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis","volume":"22","author":"Segar","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/heartjnl-2019-315481","article-title":"Identification of novel phenogroups in heart failure with preserved ejection fraction using machine learning","volume":"106","author":"\u00c5K","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.lpm.2023.104185_bib0081","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0082","article-title":"Circ heart fail","volume":"13","author":"Sabbah","year":"2020","journal-title":"Obese-Inflammatory Phenotypes Heart Failure With Preserved Ejection Fraction"},{"issue":"5","key":"10.1016\/j.lpm.2023.104185_bib0083","article-title":"Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction","volume":"5","author":"Martin","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.lpm.2023.104185_bib0084","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/HYPERTENSIONAHA.119.14057","article-title":"Medical therapies for heart failure with preserved ejection fraction","volume":"75","author":"Kjeldsen","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.lpm.2023.104185_bib0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.lpm.2023.104185_bib0086","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med."},{"issue":"15","key":"10.1016\/j.lpm.2023.104185_bib0087","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","article-title":"Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study","volume":"38","author":"Pieske","year":"2017","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.lpm.2023.104185_bib0088","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jama.2020.15922","article-title":"Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction: the VITALITY-HFpEF randomized clinical trial","volume":"324","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.lpm.2023.104185_bib0089","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.lpm.2023.104185_bib0090","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.lpm.2023.104185_bib0091","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1016\/j.lpm.2023.104185_bib0092","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1016\/j.lpm.2023.104185_bib0093","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lpm.2023.104185_bib0094","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa2030186","article-title":"Sotagliflozin in patients with diabetes and chronic kidney disease","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med."},{"issue":"10354","key":"10.1016\/j.lpm.2023.104185_bib0095","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.lpm.2023.104185_bib0096","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","article-title":"Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation signaling\/autophagy hypothesis","volume":"146","author":"Packer","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2023.104185_bib0097","first-page":"ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.lpm.2023.104185_bib0098","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/ehf2.13153","article-title":"Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial","volume":"8","author":"De Marco","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.lpm.2023.104185_bib0099","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCULATIONAHA.121.057983","article-title":"Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD Trial","volume":"145","author":"Filippatos","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lpm.2023.104185_bib0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12933-023-01899-0","article-title":"The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction","volume":"22","author":"Kintscher","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.lpm.2023.104185_bib0101","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jacc.2020.05.072","article-title":"Effect of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFpEF","volume":"76","author":"Cunningham","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.lpm.2023.104185_bib0102","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.lpm.2023.104185_bib0103","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/clc.22719","article-title":"Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2)","volume":"40","author":"Van Tassell","year":"2017","journal-title":"Clin Cardiol"},{"issue":"10","key":"10.1016\/j.lpm.2023.104185_bib0104","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-Inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.lpm.2023.104185_bib0105","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010051","article-title":"Adverse outcomes associated with interleukin-6 in patients recently hospitalized for heart failure with preserved ejection fraction","volume":"16","author":"Mooney","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0106","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2017.12.109","article-title":"Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease","volume":"255","author":"Tsujimoto","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0107","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2018.04.031","article-title":"Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction","volume":"263","author":"Tsujimoto","year":"2018","journal-title":"Int J Cardiol"},{"issue":"22","key":"10.1016\/j.lpm.2023.104185_bib0108","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.lpm.2023.104185_bib0109","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104185_bib0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2023.104185_bib0111","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2023.104185_bib0112","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2019.04.019","article-title":"Hemodynamic effects of weight loss in obesity: a systematic review and meta-analysis","volume":"7","author":"Reddy","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0113","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104185_bib0114","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2337\/cd22-as01","article-title":"Standards of medical care in diabetes-2022 abridged for primary care providers","volume":"40","author":"Association","year":"2022","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.lpm.2023.104185_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ahj.2022.11.003","article-title":"Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy","volume":"256","author":"Januzzi","year":"2023","journal-title":"Am Heart J"},{"issue":"14","key":"10.1016\/j.lpm.2023.104185_bib0116","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2023.104185_bib0117","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjcard.2020.11.039","article-title":"Meta-analysis of the usefulness of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction","volume":"142","author":"Aldaas","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0118","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurheartj\/ehac569","article-title":"Iron deficiency and cardiovascular disease","volume":"44","author":"Savarese","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2023.104185_bib0119","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ehf2.13753","article-title":"Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction","volume":"9","author":"L\u00f3pez-Vilella","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.lpm.2023.104185_bib0120","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.jacc.2014.03.034","article-title":"Implications of coronary artery disease in heart failure with preserved ejection fraction","volume":"63","author":"Hwang","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2023.104185_bib0121","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1067\/mhj.2000.108828","article-title":"Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization","volume":"140","author":"Kramer","year":"2000","journal-title":"Am Heart J"},{"issue":"16","key":"10.1016\/j.lpm.2023.104185_bib0122","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1161\/CIR.0000000000001122","article-title":"Supervised exercise training for chronic heart failure with preserved ejection fraction: a scientific statement from the American heart association and american college of cardiology","volume":"147","author":"Sachdev","year":"2023","journal-title":"Circulation"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498223000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498223000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:10:02Z","timestamp":1760105402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498223000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0755498223000222"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2023.104185","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure with preserved ejection fraction: New challenges and new hopes","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2023.104185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104185"}}